Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Chugai
Company Monitoring Page for Chugai
latest headlines for company on cafepharma
Roche autoimmune disease drug disappoints in closely watched trial
BioPharma Dive
Thu, 03/21/24 - 06:36 pm
Tags:
Roche
,
Chugai
,
clinical trials
,
myasthenia gravis
,
Enspryng
The 10 highest value R&D projects in biopharma
Fierce Biotech
Wed, 09/6/23 - 10:17 am
Tags:
R&D
,
biotech
,
Merck
,
sotatercept
,
Daiichi Sankyo
,
AstraZeneca
,
Dato-DXd
,
Novo Nordisk
,
CagriSema
,
Eli Lilly
,
donanemab
,
Karuna Therapeutics
,
Zai Lab
,
KarXT
,
Moderna Therapeutics
,
mRNA-1647
,
Novartis
,
iptacopan
,
Madrigal Pharmaceuticals
,
resmetirom
,
Cytokinetics
,
aficamten
,
Roche
,
Chugai
,
tiragolumab
ICER Deems Hemophilia Gene Therapies Worth the $2.5M Price Tag
BioSpace
Thu, 09/15/22 - 10:14 am
Tags:
hemophilia
,
gene therapy
,
ICER
,
Biomarin
,
Chugai
,
Roche
,
CSL Behring
Roche's Chugai pays Halozyme $25M to access subcutaneous delivery tech
Fierce Biotech
Tue, 03/29/22 - 10:36 am
Tags:
Roche
,
Chugai
,
drug delivery
,
subcutaneous drug delivery
,
Haolzyme Therapeutics
,
Enhanze
After Alexion buyout, AstraZeneca pays Roche $775M to settle Ultomiris patent brawl
Fierce Pharma
Thu, 03/17/22 - 10:38 am
Tags:
AstraZeneca
,
Roche
,
Chugai
,
Ultomiris
,
patents
Roche and AstraZeneca settle years long patent battle over Ultomiris — report
Endpoints
Sun, 02/20/22 - 11:48 am
Tags:
Roche
,
Chugai
,
AstraZeneca
,
Alexion
,
patents
,
Ultomiris
,
Soliris
7 drugs likely to hit $1B in annual revenue in the next 5 years
Beckers Hospital Review
Thu, 01/13/22 - 07:31 am
Tags:
FDA
,
adagrasib
,
donanemab
,
faricimab
,
lecanemab
,
tezepelumab
,
tirzepatide
,
vutrisiran
,
Eli Lilly
,
Mirati Therapeutics
,
Roche
,
Chugai
,
Eisai
,
Biogen
,
AstraZeneca
,
Amgen
,
Alnylam
Chugai’s Enspryng receives regulatory approval from FDA for neuromyelitis optica spectrum disorder
Pharmaceutical Business Review
Mon, 08/17/20 - 10:31 am
Tags:
Chugai
,
FDA
,
Enspryng
,
NMOSD
Verastem pens KRAS-focused drug licensing deal with Chugai
Fierce Biotech
Wed, 01/8/20 - 10:34 am
Tags:
Verastem
,
KRAS
,
cancer
,
Chugai
Roche's Chugai claims Alexion co-opted its patented tech in building Ultomiris
Fierce Pharma
Wed, 11/13/19 - 11:24 pm
Tags:
Alexion
,
Chugai
,
Roche
,
Ultomiris
,
patents
Roche's Chugai to set up new $1B+ lab in Yokohama, consolidating R&D
Endpoints
Wed, 05/22/19 - 10:03 am
Tags:
Chugai
,
Roche
,
Japan
,
R&D
Lilly Licenses Chugai Pharma's Oral Diabetes Drug for $50 Million Upfront
BioSpace
Thu, 09/27/18 - 11:53 am
Tags:
Eli Lilly
,
Chugai
,
OWL833
,
type 2 diabetes
Hey, wait a second. What about Roche’s PhIII hemophilia A drug?
Endpoints
Fri, 07/29/16 - 11:24 am
Tags:
Roche
,
hemophilia A
,
Chugai
,
emicizumab
,
ACE910
Galderma licenses PhII atopic dermatitis drug from Roche’s Chugai
Fierce Biotech
Fri, 07/22/16 - 11:47 am
Tags:
Galderms
,
atopic dermatitis
,
Roche
,
Chugai
,
nemolizumab
Patent Claims To Xtandi Seem Weak
Seeking Alpha
Tue, 08/11/15 - 11:20 am
Tags:
patents
,
Xtandi
,
Chugai
,
Roche
Chugai Pharma Appears To Own U.S., Japan And EU Patent Rights To Medivation's Xtandi
Seeking Alpha
Tue, 05/12/15 - 04:29 pm
Tags:
Chugai
,
Medivation
,
Xtandi
,
patents
,
Japan
,
Europe
As PhII data looms, Chugai inks a $205M stem cell deal with Athersys
Fierce Biotech
Mon, 03/2/15 - 09:48 pm
Tags:
Chugai
,
stem cells
,
Athersys
Chugai pours $374M into its Singapore R&D shop
Fierce Biotech
Mon, 02/2/15 - 05:55 pm
Tags:
Chugai
,
Singapore
,
R&D
,
Chugai Pharmabody Research
Roche Sees ‘No Urgency’ to Buy Rest of Chugai, CFO Says
Bloomberg
Wed, 01/14/15 - 10:14 am
Tags:
Roche
,
Chugai
,
M&A
Roche Said to Have Decided Against Bid for Rest of Chugai
Bloomberg
Mon, 08/25/14 - 09:10 am
Tags:
Roche
,
Chugai
,
M&A
,
InterMune
Pages
1
2
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.